Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation
Condition(s):AsthmaLast Updated:July 6, 2021Completed
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:July 6, 2021Completed
Condition(s):Diabetes Mellitus; Chronic Obstructive Pulmonary DiseaseLast Updated:February 2, 2010Terminated
Condition(s):Moderate Asthma Exacerbation; Severe Asthma ExacerbationLast Updated:February 21, 2024Recruiting
Condition(s):Lung Diseases, ObstructiveLast Updated:April 20, 2016Completed
Condition(s):Asthma Acute; Asthma in ChildrenLast Updated:May 2, 2018Unknown status
Condition(s):AsthmaLast Updated:November 11, 2009Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:October 27, 2021Withdrawn
Condition(s):Patients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisLast Updated:October 23, 2015Completed
Condition(s):Chronic Obstructive Pulmonary Disease; COPD; Copd Exacerbation Acute; COPD ExacerbationLast Updated:July 18, 2019Completed
Condition(s):Chronic Obstructive Pulmonary Disease (COPD)Last Updated:August 17, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.